Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SoloPak Pharmaceuticals was a specialty pharmaceutical company that focused on the development and manufacture of sterile injectable generic drugs. Based in Elk Grove Village, Illinois, the company provided a wide range of essential medications to the hospital and institutional markets, including anticoagulants, electrolytes, and anesthetics. SoloPak was particularly known for its production of heparin and various electrolyte replacement therapies. In 1996, the company was acquired by Smith & Nephew for approximately $125 million, following a period of significant growth and a notable product recall. The business was later sold to Allegiance Corporation and eventually integrated into Cardinal Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SoloPak Pharmaceuticals.